Pneumonia News and Research

Latest Pneumonia News and Research

AU Summit panel focuses on water, sanitation to meet MDG targets in Africa

African countries should focus on preventing diarrhea - the biggest killer of children in Africa - in order to achieve Millennium Development Goal targets, Yunia Musaazi, WaterAid's East Africa policy advisor, told delegates at the 15th African Union Summit, PANA/Afrique en ligne reports.

26 Jul 2010

Scientists study Legionella's reprogramming on cells for survival, propagation

When it infects the lungs, the Legionnaire's bacterium Legionella pneumophila causes acute pneumonia. The pathogen's modus operandi is particularly ingenious: it infiltrates deliberately into cells of the human immune system and injects a host of proteins which then interfere in the normal cellular processes. Scientists from the Max Planck Institute of Molecular Physiology in Dortmund have now discovered how Legionella reprogrammes the cells to ensure its own survival and to propagate. They examined a protein used by the pathogen to divert the material transport within the cells for its own purposes.

26 Jul 2010

Advanced Life Sciences enters debt for equity exchange agreement with CEO

Advanced Life Sciences Holdings, Inc., a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, oncology and respiratory diseases, today announced that the Company has entered into a debt for equity exchange agreement with its chairman and CEO Michael T. Flavin, Ph.D.

23 Jul 2010

New rules Thursday on appealing insurance claims, states take lead in health reform implementation

Kaiser Health News /The Washington Post obtained a summary of new rules to be released Thursday by the Obama administration that will make it easier for consumers to appeal the denials of their health insurance claims as the White House tries to "boost political support" for the new health law.

23 Jul 2010

Pneumonia, diarrhea, and malaria cause death of 6 million of world's poorest children

A Johns Hopkins University scientist, whose team of researchers recently identified pneumonia, diarrhea, and malaria as the primary causes of death of 6 million of the world's poorest children, today called on leaders in donor and developing nations to take action to address the terrible death toll.

23 Jul 2010

Onconase, Amphinase 2 show positive results for SARS virus: Tamir Biotechnology

Tamir Biotechnology, Inc. announced today that scientists supported by the National Institute of Allergy and Infectious Diseases confirmed that testing of two (2) of the company's compounds Onconase (Ranpirnase), and recombinant Amphinase 2 showed positive in vitro results for Severe Acute Respiratory Syndrome, also known as (SARS) virus.

22 Jul 2010

Medicare Star Support Program launched to help Medicare Advantage plans boost star ratings

Health Dialog today announced that it has launched its Medicare Star Support Program to help Medicare Advantage plans boost their Health Plan Quality and Performance ("Star") Ratings and ensure that seniors are getting the best care possible. Star ratings are calculated by the Centers for Medicare & Medicaid Services and can range from 1 to 5, with 5 representing the highest quality.

21 Jul 2010

AiCuris presents preclinical data on AIC246 anti-HCMV drug at International Herpesvirus Workshop

AiCuris announced today publication of preclinical data on AIC246, at the International Herpesvirus Workshop in Salt Lake City, Utah, USA from 24 – 29 July 2010. AIC246 is a novel anti-HCMV drug currently in clinical phase 2 testing.

21 Jul 2010

Phase 2 CUBICIN study for prosthetic joint infections meets primary endpoint

Cubist Pharmaceuticals, Inc., a leading acute care therapeutics company, today announced that its Phase 2 safety study of CUBICIN (daptomycin for injection) in the treatment of prosthetic joint infections caused by certain Gram positive pathogens met its study objectives. This study was a first-of-its-kind randomized controlled Phase 2 trial studying anti-infective therapy in the setting of 2-stage surgery for the replacement of infected prosthetic hip or knee joints.

19 Jul 2010

Pneumococcal conjugate vaccine appears to reduce pneumonia, serious complications in infants: Research

A pneumococcal conjugate vaccine introduced in the U.S. 10 years ago appears to reduce pneumonia and serious associated complications, such as blood infections, in the vaccine's target range, children less than a year old, according to new research.

19 Jul 2010

Insight into inner functional mechanisms of new bacterial infection target

In any battle, sizing up one's opponent is a critical first step. For researchers fighting a bacterial infection, that means assessing every nook and cranny of the malicious microorganism and identifying which ones to attack.

14 Jul 2010

Universal surveillance for MRSA decreased HAIs related to devices: Study

Pitt County Memorial Hospital today announced results of a study demonstrating that universal surveillance for methicillin-resistant Staphylococcus aureus decreased health care-associated infections related to devices. Infection rates decreased 68 percent for ventilator-associated pneumonias; 51 percent for central line-associated bacteremias; and 49 percent for catheter-associated urinary tract infections.

14 Jul 2010

LSUHSC Professor awarded $2.1M grant to determine role of PCP

Dr. Jay Kolls, Professor and Chairman of Genetics at the LSU Health Sciences Center New Orleans School of Medicine, has been awarded a $2.1 million grant over five years by the National Heart, Lung, and Blood Institute of the National Institutes of Health to determine the role and identify which T-helper cells fight the opportunistic infection, Pneumocystis carinii pneumonia, which can be a complication of HIV/AIDS.

14 Jul 2010

AlphaRx reports positive preclinical results of GAI-122 injectable nanoemulsion for Acute Ischemic Stroke

AlphaRx, Inc. announced positive preclinical results of GAI-122 injectable nanoemulsion, a Mitochondria-targeted neuroprotective drug candidate being developed for the treatment of Acute Ischemic Stroke. The results will be delivered as a podium presentation during the 37th Annual Meeting and Exposition of the Controlled Release Society in Portland, Oregon July 10 - 14, 2010.

13 Jul 2010

Hospitals adopt advanced computer technology to prevent HAIs

Hospitals that adopt advanced computer technology to identify healthcare-associated infections are more likely to have implemented best practices to prevent such infections, according to research presented today at the 37th Annual Conference and International Meeting of the Association for Professionals in Infection Control and Epidemiology.

13 Jul 2010

FDA accepts to review sNDA for SPRYCEL for treating adult patients with CML

Bristol-Myers Squibb Company and Otsuka Pharmaceutical Co., Ltd. today announced that the U.S. Food and Drug Administration has accepted for filing and review the supplemental New Drug Application for SPRYCEL (dasatinib) for the treatment of adult patients with newly diagnosed chronic myeloid leukemia in chronic phase.

12 Jul 2010

Advanced Life Sciences announces positive results from preclinical studies of Restanza IV

Advanced Life Sciences Holdings, Inc., a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, oncology and respiratory diseases, today announced positive results from preclinical toxicology and pharmacokinetic studies of an intravenous (IV) formulation of its novel antibiotic, Restanza™ that support its use in a hospital setting.

8 Jul 2010

New information about quality of care available in America's hospitals added to new HHS website

Important new information about the quality of care available in America's outpatient and emergency departments, including how well hospitals care for patients with heart attacks and protect outpatients from surgical infections was added to the new HHS website HealthCare.gov.

8 Jul 2010

Heart attack death rates drop in hospitals; CDC reports increase in colon cancer screening rate

USA Today: Hospital heart attack death rates fell, according to new Medicare data. "Death rates at 4,569 hospitals that treat Medicare patients who suffer heart attacks fell by almost half a percentage point, from a national average of 16.6% last year to 16.2%. Death rates for most hospitals ranged from about 14.5% to 17.9%. ...

8 Jul 2010

HQA applauds public availability of hospital quality information at Hospital Compare website

The Hospital Quality Alliance today applauded the public availability of new information on hospital quality of care at the Hospital Compare website. The HQA is a broad working group of hospitals, consumer representatives, physician and nursing organizations, employers and payers, oversight organizations and government agencies dedicated to improving health care quality and making useful and understandable information about hospital quality available to the public.

8 Jul 2010

Pneumonia News and Research

Latest Pneumonia News and Research

AU Summit panel focuses on water, sanitation to meet MDG targets in Africa

Scientists study Legionella's reprogramming on cells for survival, propagation

Advanced Life Sciences enters debt for equity exchange agreement with CEO

New rules Thursday on appealing insurance claims, states take lead in health reform implementation

Pneumonia, diarrhea, and malaria cause death of 6 million of world's poorest children

Onconase, Amphinase 2 show positive results for SARS virus: Tamir Biotechnology

Medicare Star Support Program launched to help Medicare Advantage plans boost star ratings

AiCuris presents preclinical data on AIC246 anti-HCMV drug at International Herpesvirus Workshop

Phase 2 CUBICIN study for prosthetic joint infections meets primary endpoint

Pneumococcal conjugate vaccine appears to reduce pneumonia, serious complications in infants: Research

Insight into inner functional mechanisms of new bacterial infection target

Universal surveillance for MRSA decreased HAIs related to devices: Study

LSUHSC Professor awarded $2.1M grant to determine role of PCP

AlphaRx reports positive preclinical results of GAI-122 injectable nanoemulsion for Acute Ischemic Stroke

Hospitals adopt advanced computer technology to prevent HAIs

FDA accepts to review sNDA for SPRYCEL for treating adult patients with CML

Advanced Life Sciences announces positive results from preclinical studies of Restanza IV

New information about quality of care available in America's hospitals added to new HHS website

Heart attack death rates drop in hospitals; CDC reports increase in colon cancer screening rate

HQA applauds public availability of hospital quality information at Hospital Compare website

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Pneumonia News and Research

Latest Pneumonia News and Research

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Newsletters you may be interested in